| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $657.3M | -4.9% |
| Cost of Revenue | $485.4M | -1.3% |
| Gross Profit | $171.9M | -13.8% |
| R&D Expense | $89.9M | +2.0% |
| SG&A Expense | $85.7M | -3.5% |
| Operating Income | -$3.8M | -116.7% |
| Pre-tax Income | -$2.6M | -113.4% |
| Income Tax | $3.6M | -38.5% |
| Net Income | -$11.1M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $175.1M | -10.3% |
| Accounts Receivable | $12.5M | -44.0% |
| Inventory | $195.8M | +6.8% |
| Current Assets | $398.0M | -6.1% |
| Total Assets | $1.15B | -4.6% |
| Current Liabilities | $154.2M | -10.6% |
| Long-term Debt | $26.7M | -30.3% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $25.7M | +25.6% |
| Capital Expenditures | $37.1M | -66.4% |
| Investing Cash Flow | -$35.7M | +67.4% |
| Financing Cash Flow | -$9.9M | +66.6% |
| Free Cash Flow | -$11.4M | +87.4% |
| -189.6% |
| EPS (Basic) | -$0.39 | -186.7% |
| EPS (Diluted) | -$0.39 | -192.9% |
| Total Liabilities |
| $253.4M |
| -19.8% |
| Stockholders' Equity | $891.6M | +0.9% |